Overview
Diabetes Mellitus: Prevention strategies, predictors, treatment effects; kidney and other complications including cardiovascular outcomes. Utilization of EHR data to construct tools to improve the care of diabetes and comorbid conditions.
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Endocrinology, Metabolism, and Nutrition,
Medicine
Member in the Duke Clinical Research Institute
·
2008 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Journal Article Am Heart J · April 2025 BACKGROUND: SGLT-2i and GLP-1RA are recommended for persons with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD); for those prescribed, little is known about reasons for discontinuation. METHODS: From the COORDINATE-Diabetes randomized t ... Full text Link to item CiteStriving for early effective glycaemic and weight management in type 2 diabetes: A narrative review.
Journal Article Diabetes Obes Metab · April 2025 Despite the recognition by key guidelines that achieving early glycaemic control has important benefits in individuals with type 2 diabetes (T2D) and that addressing excess adiposity is one of the central components of comprehensive person-centred T2D care ... Full text Link to item CiteThe Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus.
Journal Article J Diabetes Sci Technol · March 2025 Ultra-rapid-acting insulin analogs (URAA) are a further development and refinement of rapid-acting insulin analogs. Because of their adapted formulation, URAA provide an even faster pharmacokinetics and thus an accelerated onset of insulin action than conv ... Full text Link to item CiteRecent Grants
Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029EASi-KIDNEY: The Study of Heart and Kidney Protection with "BI 690517"
Clinical TrialPrincipal Investigator · Awarded by The Chancellor Masters and Scholars of the University of Oxford · 2023 - 2029Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) - Microbiome Collection
Clinical TrialPrincipal Investigator · Awarded by The George Washington University · 2012 - 2025View All Grants
Education, Training & Certifications
University of Virginia ·
1993
M.D.